Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Children and teens with vitiligo are significantly more likely to develop thyroid disease than their peers, according to a new meta-analysis. The pooled prevalence of thyroid disease among young vitiligo patients was nearly 11%, with the risk far higher in those with nonsegmental vitiligo. Experts now recommend routine thyroid screening for this group.
A large meta-analysis published in Pediatric Dermatology has found that thyroid disease is considerably more common in children and adolescents with vitiligo compared to the general pediatric population. Analyzing 27 studies across 15 countries and involving over 6,200 young patients, researchers found a pooled thyroid disease prevalence of about 11% — with rates in individual studies ranging as high as 55%.
The risk wasn't evenly distributed. Kids with nonsegmental vitiligo (NSV) — the more common form — had a thyroid disease prevalence of 15.9%, compared to just 0.8% in those with segmental vitiligo. Girls were also disproportionately affected, outnumbering boys at a ratio of roughly 1.4:1. The most frequent abnormalities detected were antithyroid antibody positivity and elevated TSH levels.
By the Numbers:
Why it matters: These findings reinforce the autoimmune connection between vitiligo and thyroid disease in young patients. The authors recommend baseline and periodic thyroid screening — including TSH, anti-TPO, and anti-TG antibodies — for all children diagnosed with nonsegmental vitiligo, enabling earlier detection and management of a potentially silent but impactful condition.
